Intravenous administration and abuse of bupropion: A case report and a review of the literature

Journal of Addiction Medicine

Volumn 8, Issue 4, 2014, Pages 290-293

  Oppek, Kirsten ^a   Koller, Gabriele ^a   Zwergal, Andreas ^b   Pogarell, Oliver ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Dependence on bupropion; Intravenous administration of bupropion; Polysubstance dependence

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; CASE REPORT; FEMALE; HUMAN; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; FEMALE; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84905818500     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000044     Document Type: Review

References (36)

1. Baribeau D, Araki KF. Intravenous bupropion: a previously undocumented method of abuse of a commonly prescribed antidepressant agent. J Addict Med 2013;7(3):216-217.
2. Carrus D, Schifano F. Pregabalin misuse-related issues; intake of large dosages, drug-smoking allegations, and possible association with myositis: two case reports. J Clin Psychopharmacol 2012;32(6): 839-840.
3. Chevassus H, Farret A, Gagnol JP, et al. Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155). Eur J Clin Pharmacol 2013;69(4):779-787.
4. Dwoskin LP, Rauhut AS, King-Pospisil KA, et al. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 2006;12(3/4):178-207.
5. Filipetto FA, Zipp CP, Coren JS. Potential for pregabalin abuse or diversion after pastdrug-seeking behavior.J Am Osteopath Assoc 2010;110(10):605-607.
6. Gahr M, Franke B, Freudenmann RW, et al. Concerns about pregabalin: further experience with its potential of causing addictive behaviours. J Addict Med 2013;7(2):147-149.
7. Gobbi G, Slater S, Boucher N, et al. Neurochemical and psychotropic effects of bupropion in healthy male subjects. J Clin Psychopharmacol 2003;23(3):233-239.
8. Griffith JD, Carranza J, Griffith C, et al. Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry 1983;44(5) (pt 2):206-208.
9. Grosshans M, Lemenager T, Vollmert C, et al. Pregabalin abuse among opiate addicted patients. Eur J Clin Pharmacol 2013;69(12):2021-2025.
10. Grosshans M, Mutschler J, Hermann D, et al. Pregabalin abuse, dependence, and withdrawal: a case report. Am J Psychiatry 2010;167(7):869.
11. Hamilton MJ, Smith PR, Peck AW. Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers. Br J Clin Pharmacol 1983;15(3):367-374.
12. Hill S, Sikand H, Lee J. A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry 2007;9(1): 67-69.
13. Javelot T, Javelot H, Baratta A, et al. Acute psychotic disorders related to bupropion: review of the literature. Encephale 2010;36(6):461-471.
14. Khurshid KA, Decker DH. Bupropion insufflation in a teenager. J Child Adolesc Psychopharmacol 2004;14(1):157-158.
15. Kim D, Steinhart B. Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. CJEM 2010;12(2):158-161.
16. Kumar S, Kodela S, Detweiler JG, et al. Bupropion-induced psychosis: folklore or a fact? A systematic review of the literature. Gen Hosp Psychiatry 2011;33(6):612-617.
17. Lamb RJ, Griffiths RR. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology (Berl) 1990;102(2):183-190.
18. Langguth B, Hajak G, Landgrebe M, Unglaub W. Abuse potential of bupropion nasal insufflation: a case report. J Clin Psychopharmacol 2009;29(6):618-619.
19. McCormick J. Recreational bupropion abuse in a teenager. Br J Clin Pharmacol 2002;53(2):214.
20. Millar J, Sadasivan S, Weatherup N, et al. Lyrica night-recreational pre-gabalin abuse in an urban emergency department. Emerg Med J 2013; 30:874.
21. Miller L, Griffith J. A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers. Psychopharmacology (Berl) 1983;80(3):199-205.
22. Moreira R. The efficacy and tolerability of bupropion in the treatment of major depressive disorder. Clin Drug Investig 2011;31(suppl 1): 5-17.
23. Nomikos GG, Damsma G, Wenkstern D, et al. Acute effects of bupro-pion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology 1989;2(4):273-279.
24. Nomikos GG, Damsma G, Wenkstern D, et al. Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 1992;7(1):7-14.
25. Papazisis G, Garyfallos G, Sardeli C, et al. Pregabalin abuse after past substance-seeking behavior. Int J Clin Pharmacol Ther 2013;51(5):441-442.
26. Peck AW, Bye CE, Clubley M, et al. A comparison ofbupropion hydrochloride with dexamphetamine and amitriptyline in healthy subjects. Br J Clin Pharmacol 1979;7(5):469-478.
27. Reeves RR, Ladner ME. Additional evidence of the abuse potential of bupro-pion. J Clin Psychopharmacol 2013;33:584-585.
28. Rush CR, Kollins SH, Pazzaglia PJ. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 1998;6(1):32-44.
29. Schwan S, Sundström A, Stjernberg E, et al. A signal for an abuse liability for pregabalin-results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Clin Pharmacol 2010;66(9):947-953.
30. Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med 2004;27(2):147-151.
31. Tassone DM, Boyce E, Guyer J, et al. Pregabalin:anovel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Ther 2007;29(1):26-48.
32. Tella SR, Ladenheim B, Andrews AM, et al. Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neu-roadaptive changes in the mesolimbic dopaminergic system. J Neurosci 1996;16(23):7416-7427.
33. Tella SR, Ladenheim B, Cadet JL. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. J Pharmacol Exp Ther 1997;281(1):508-513.
34. Welsh CJ. Seizures induced by insufflation of bupropion. N Engl J Med 2002;347(12):951.
35. Yoon G, Westermeyer J. Intranasal bupropion abuse: case report. Am J Addict 2013;22(2):180.
36. Zernig G, De Wit H, Telser S, et al. Subjective effects of slow-release bupro-pion versus caffeine as determined in a quasi-naturalistic setting. Pharmacology 2004;70:206-215.